Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible.
He said, “The study was published in Lancet on hydroxychloroquine and chloroquine and its effect on COVID-19 is an observational study.” He added that the statistical analysis in the Lancet paper is faulty.
Watch the full video for more.